We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
German drugmaker Merck KgaA has announced that it has sold its electronic
chemicals business to German industrial giant BASF for EUR270mn (US$351.91mn).
The Japanese Ministry of Health, Labour and Welfare has cleared a
rheumatoid arthritis treatment developed by US drugmaker Wyeth and local drug
major Takeda, according to international reports.
According to a report by US management consultancy McKinsey,
the approval of India's new pharmaceuticals intellectual property legislation
is likely to prompt multinationals to launch more patent-protected products.
Speaking at an international conference on pharmaceutical technical
cooperation, a senior Brazilian health official has renewed claims that the
government will foment local generic production of latest-generation patented
HIV/AIDS treatments.
UK- and Sweden-based drug major AstraZeneca has reported encouraging fourth-quarter
results, with earnings rising 52% year-on-year to US$968mn. Sales totalled some
US$5.8bn in the period.